Australia markets close in 7 minutes

Jiangsu Recbio Technology Co., Ltd. (2179.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
9.160-0.010 (-0.11%)
As of 01:50PM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 4.43B
Enterprise value 4.23B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.85
Enterprise value/revenue N/A
Enterprise value/EBITDA -5.89

Trading information

Stock price history

Beta (5Y monthly) -0.14
52-week change 3-28.44%
S&P500 52-week change 324.43%
52-week high 313.040
52-week low 37.890
50-day moving average 38.888
200-day moving average 39.804

Share statistics

Avg vol (3-month) 310.23k
Avg vol (10-day) 350
Shares outstanding 5316.14M
Implied shares outstanding 6482.96M
Float 8184.71M
% held by insiders 149.25%
% held by institutions 135.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,128.76%

Management effectiveness

Return on assets (ttm)-17.17%
Return on equity (ttm)-42.03%

Income statement

Revenue (ttm)30.38M
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)667.90%
Gross profit (ttm)N/A
EBITDA -569.87M
Net income avi to common (ttm)-571.96M
Diluted EPS (ttm)-1.280
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)837.76M
Total cash per share (mrq)1.75
Total debt (mrq)650.8M
Total debt/equity (mrq)60.77%
Current ratio (mrq)2.54
Book value per share (mrq)2.24

Cash flow statement

Operating cash flow (ttm)-638.07M
Levered free cash flow (ttm)-637.15M